DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
74% of users discontinue within 1 year. Reasons: cost, side effects, "graduation" assumption, supply issues. Weight regain is the rule, not the exception, without a maintenance plan.
Within 4 weeks of last dose, drug effect fades (semaglutide half-life ~1 week; ~5 weeks to clear). Appetite returns toward baseline. STEP-4 data: ~67% of lost weight regained within 1 year off-drug. Some patients keep weight off — typically those with substantial behavioral change.
Hunger surge in weeks 2-4 after stopping. Plan ahead: protein-dense, fiber-rich meals; structured eating schedule. Track body composition, not just weight. Stress-eating relapse risk.
STEP-4: discontinuation at week 20 followed by 48 weeks off-drug → ~67% weight regain. Continuous use group: weight loss sustained. The drug works as long as you take it.
Most patients stop because they think they have "finished" — but obesity treatment is more like HTN treatment than antibiotic treatment. If cost is the issue, switch to LillyDirect vials ($349-499/mo) before stopping. If side effects, dose-reduce first.
Editorial summary, not medical advice. Cycling, dose changes, and discontinuation should be coordinated with your prescriber.